Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders

E-ISSN： 1996-3181|13|10|1770-1786

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.10, 2014-12, pp. : 1770-1786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A. Heilig M. Rupniak N.M.J. Steckler T. Griebel G.

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

Current Neuropharmacology, Vol. 12, Iss. 2, 2014-03 ,pp. : 108-119

Bentham Science Publishers

Access to resources Recommend Favorite

Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 225-232

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Targets in Neuropsychiatric Disorders: The Neuroepigenome

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1831-1839

Bentham Science Publishers

Access to resources Recommend Favorite